High cost and demand for old cancer drug sparks crisisDecember 5, 2022CLLCellular TherapyMantle Cell Lymphoma
CAR T-cell therapy neurotoxicity linked to NfL elevationsOctober 3, 2022Cellular TherapyAggressive LymphomasALLB Cell LymphomaMultiple MyelomaMixed TopicsCLL
First drug therapy approved for childhood GVHDAugust 26, 2022ALLAMLMixed TopicsPediatricsCLLMantle Cell LymphomaTransplant
Where women’s voices still get heard lessAugust 18, 2022Diversity in MedicineMixed TopicsTranslational ResearchCLL
Phase 3 data: Zanubrutinib bests standard CLL treatmentAugust 16, 2022CLLMantle Cell LymphomaB Cell Lymphoma
Many die waiting for `last-chance’ therapyAugust 2, 2022Multiple MyelomaAggressive LymphomasALLCLLCellular TherapyMixed Topics
Drug shortages plague hematology, but preparedness helpsJuly 18, 2022CLLALLHodgkin LymphomaMixed TopicsBusiness of MedicineB Cell LymphomaMantle Cell Lymphoma
